InsiderTrades.com logo

AXLA Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 2.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Axcella Health Insider Trading History Chart

This chart shows the insider buying and selling history at Axcella Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Axcella Health Share Price & Price History

Current Price: $0.40
Price Change: +0.30 (1.20%)
As of 12/29/2023 01:00 AM ET

This chart shows the closing price history over time for AXLA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Axcella Health Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/1/2023Margaret KozielInsiderSell27$14.50$391.50995View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Axcella Health (NASDAQ:AXLA)

65.07% of Axcella Health stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AXLA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Axcella Health Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/14/2023Schonfeld Strategic Advisors LLC100,600$1.05M0.0%N/A3.412%Search for SEC Filing on Google Icon
5/1/2023Virtu Financial LLC83,456$40K0.0%N/A0.113%Search for SEC Filing on Google Icon
2/14/2023Flagship Pioneering Inc.29,251,545$9.36M0.3%+55.0%39.766%Search for SEC Filing on Google Icon
7/15/2022Pinnacle Private Wealth LLC61,500$0.13M0.0%+108.5%0.117%Search for SEC Filing on Google Icon
5/26/2022HarbourVest Partners LLC4,378,661$11.25M2.3%+55.9%8.328%Search for SEC Filing on Google Icon
5/17/2022Flagship Pioneering Inc.18,867,785$48.49M1.1%+50.4%35.884%Search for SEC Filing on Google Icon
5/11/2022Edgewood Management LLC100,000$0.26M0.0%+33.3%0.190%Search for SEC Filing on Google Icon
5/3/2022Cutter & CO Brokerage Inc.19,800$51K0.0%-24.7%0.038%Search for SEC Filing on Google Icon
4/29/2022Pinnacle Private Wealth LLC29,500$76K0.0%+43.9%0.056%Search for SEC Filing on Google Icon
2/10/2022Cutter & CO Brokerage Inc.26,300$55K0.0%-25.5%0.068%Search for SEC Filing on Google Icon
2/7/2022Pinnacle Private Wealth LLC20,500$43K0.0%N/A0.053%Search for SEC Filing on Google Icon
11/15/2021Marshall Wace LLP40,017$0.12M0.0%-44.7%0.105%Search for SEC Filing on Google Icon
8/16/2021State Street Corp70,676$0.28M0.0%-68.5%0.185%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp35,158$0.14M0.0%-79.9%0.092%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Axcella Health logo
Axcella Health Inc. operates as a clinical-stage biotechnology company in the United States. The company treats complex diseases using endogenous metabolic modulators. Its product pipeline includes AXA1125 that is in Phase 2a clinical trial for long COVID therapy for patients, as well as Phase 2b clinical trial for treating non-alcoholic steatohepatitis; and AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.
Read More on Axcella Health

Today's Range

Now: $0.40
Low: $0.36
High: $0.51

50 Day Range

MA: $0.84
Low: $0.40
High: $4.58

52 Week Range

Now: $0.40
Low: $0.34
High: $41.25

Volume

6,782 shs

Average Volume

267,009 shs

Market Capitalization

$1.18 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.46